Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

198
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
198
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

265
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
265
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Censoring Survival Data01:09

Censoring Survival Data

241
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
241

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CLEAR-AI: confounder-aware learning for equitable and accurate reasoning in AI for diagnosis.

Journal of medical imaging (Bellingham, Wash.)·2026
Same author

Multimodal artificial intelligence models for radiology.

BJR artificial intelligence·2026
Same author

Extraction of distant recurrence sites for breast cancer patients from free-text clinical notes using large language models.

Journal of biomedical informatics·2026
Same author

Biomedical multimodal large language models: From model-centric development to clinically grounded evaluation and integration.

Journal of biomedical informatics·2026
Same author

EchoAtlas: A Conversational, Multi-View Vision-Language Foundation Model for Echocardiography Interpretation and Clinical Reasoning.

medRxiv : the preprint server for health sciences·2026
Same author

Performance of clinical breast cancer risk prediction models versus a mammography-based artificial intelligence risk model.

Journal of the National Cancer Institute·2026
Same journal

Federated Function-on-function Regression with an Efficient Gradient Boosting Algorithm for Privacy-Preserving Telemedicine.

IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society·2026
Same journal

MUSE-Net: Missingness-aware mUlti-branching Self-attention Encoder for Irregular Longitudinal Electronic Health Records.

IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society·2026
Same journal

Development and Quantitative Evaluation of a Novel Autonomous <i>In situ</i> Bioprinting Surgical Robotic Framework For Treatment of Volumetric Muscle Loss Injuries.

IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society·2025
Same journal

A Novel Hybrid Ordinal Learning Model with Health Care Application.

IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society·2025
Same journal

Distribution-agnostic Probabilistic Few-shot Learning for Multimodal Recognition and Prediction.

IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society·2025
Same journal

Oral-Anatomical Knowledge-Informed Semi-Supervised Learning for 3D Dental CBCT Segmentation and Lesion Detection.

IEEE transactions on automation science and engineering : a publication of the IEEE Robotics and Automation Society·2025
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

380

SCGAN: Sparse CounterGAN for Counterfactual Explanations in Breast Cancer Prediction.

Siqiong Zhou1, Upala J Islam1, Nicholaus Pfeiffer2

  • 1School of Computing and Augmented Intelligence, Arizona State University.

IEEE Transactions on Automation Science and Engineering : a Publication of the IEEE Robotics and Automation Society
|July 30, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces Sparse CounteRGAN (SCGAN) to understand how imaging, clinical, and molecular (ICM) features influence breast cancer treatment response after neoadjuvant systemic therapy (NST). SCGAN generates realistic, sparse, and diverse counterfactuals for causal inference.

Keywords:
counterfactual explanationsgenerative adversarial networksmagnetic resonance imagingradiomics

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

380
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Radiomics and Medical Imaging
  • Computational Biology and Bioinformatics
  • Machine Learning and Artificial Intelligence

Background:

  • Radiomics from MRI show promise in predicting breast cancer treatment response to neoadjuvant systemic therapy (NST).
  • Understanding causal links between Imaging, Clinical, and Molecular (ICM) features and treatment response is crucial for personalized medicine.
  • Existing counterfactual explanation methods face challenges with high dimensionality, realism, and feature confounding.

Purpose of the Study:

  • To propose a novel method, Sparse CounteRGAN (SCGAN), for generating realistic and interpretable counterfactual explanations.
  • To reveal causal relationships between ICM features and treatment response in breast cancer patients undergoing NST.
  • To address limitations of existing counterfactual generation techniques.

Main Methods:

  • Developed SCGAN, a generative approach learning data distribution for realistic counterfactual instance generation.
  • Incorporated dropout training for the discriminator to enforce sparsity in counterfactuals.
  • Introduced a diversity term in the loss function to maximize distances between generated counterfactuals.

Main Results:

  • SCGAN successfully generates sparse and diverse counterfactual instances.
  • The generated counterfactuals demonstrate plausibility and feasibility.
  • Evaluated on multiple datasets, SCGAN outperforms existing methods in revealing causal relationships.

Conclusions:

  • SCGAN provides a valuable tool for causal inference in high-dimensional medical data.
  • The method enhances understanding of ICM features' impact on breast cancer treatment response.
  • SCGAN facilitates more informed clinical decision-making for breast cancer management.